首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week randomized treat‐to‐target phase III trial

【2h】

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week randomized treat‐to‐target phase III trial

机译：速效门冬胰岛素与1型糖尿病（门诊1）中的门冬胰岛素的疗效和安全性：一项为期52周随机靶向治疗的III期临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsTo compare the safety and efficacy of fast‐acting insulin aspart (faster aspart) with conventional insulin aspart (IAsp) in adults with type 1 diabetes (T1D).

机译：目的比较1型糖尿病（T1D）成人中速效门冬胰岛素（更快的门冬）与常规门冬胰岛素（IAsp）的安全性和有效性。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
Chantal Mathieu; Bruce W. Bode; Edward Franek; Athena Philis‐Tsimikas; Ludger Rose; Tina Graungaard; Anne Birk Østerskov; David Russell‐Jones;
展开▼
作者单位

展开▼
年(卷),期 -1(20),5
年度 -1
页码 1148–1155
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
insulin therapy type 1 diabetes;

机译：胰岛素治疗;1型糖尿病;

相似文献

外文文献
中文文献
专利

1. 单发肝细胞癌合并微血管侵犯患者根治性切除术后辅助经导管动脉化疗栓塞治疗的疗效和安全性:一项随机临床试验 [J] . Wei Wei, Lie Zheng, Min-Shan Chen, 癌症（英文版） . 2019,第003期
2. Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial [J] . Mathieu Chantal, Bode Bruce W., Franek Edward, Diabetes, obesity & metabolism . 2018,第5期

机译：快速胰岛素Aspart的功效和安全性与1型糖尿病胰岛素Aspart（发病1）：A 52周，随机，治疗靶III期试验
3. Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan [J] . Hassanein Mohamed, Echtay Akram Salim, Malek Rachid, Diabetes research and clinical practice . 2018,第期

机译：原文：胰岛素Degludec /胰岛素Aspart的疗效和安全性分析与双相胰岛素Aspart 30：2型糖尿病患者患者的3，多期，国际，开放标签，随机治疗对目标试验
4. Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial [J] . Yang Wenying, Ma Jianhua, Hong Tianpei, Diabetes, obesity & metabolism . 2019,第7期

机译：胰岛素Degludec /胰岛素Aspart的疗效和安全性与2型糖尿病的中国成人双相胰岛素Aspart 30：III期，开放标签，2：1随机治疗，目标试验
5. Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator^* [C] . Roberto Visentin, Michele Schiavon, Clemens Giegerich, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：长效胰岛素在糖尿病治疗中的作用：采用UVA / Padova 1型糖尿病模拟器的Silico临床试验^*
6. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
7. Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III open‐label 2:1 randomized treat‐to‐target trial [O] . Wenying Yang, Jianhua Ma, Tianpei Hong, -1

机译：地格曲胰岛素/门冬胰岛素与双相门冬胰岛素30在中国2型糖尿病成年人中的疗效和安全性：III期开放标签2：1随机针对治疗的试验
8. Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week, randomized, treat‐to‐target, phase III trial [O] . Chantal Mathieu, Bruce W. Bode, Edward Franek, 2018

机译：与1型糖尿病胰岛素Aspart相比，快速胰岛素Aspart的功效和安全性（发病1）：52周，随机治疗目标，III期试验

Efficacy and safety of fast‐acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52‐week randomized treat‐to‐target phase III trial

摘要

著录项

相似文献

相关主题

期刊订阅